.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

KEPPRA Drug Profile

« Back to Dashboard
Keppra is a drug marketed by Ucb Inc and is included in four NDAs. It is available from seven suppliers. There are two patents protecting this drug and three Paragraph IV challenges.

The generic ingredient in KEPPRA is levetiracetam. There are thirty-four drug master file entries for this compound. Ninety suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the levetiracetam profile page.

Summary for Tradename: KEPPRA

Patents:2
Applicants:1
NDAs:4
Suppliers / Packagers: see list7
Drug Prices: :see details

Pharmacology for Tradename: KEPPRA

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc
KEPPRA
levetiracetam
SOLUTION;ORAL021505-001Jul 15, 2003RXYes► subscribe► subscribe
Ucb Inc
KEPPRA XR
levetiracetam
TABLET, EXTENDED RELEASE;ORAL022285-001Sep 12, 2008RXNo7,858,122► subscribeY ► subscribe
Ucb Inc
KEPPRA
levetiracetam
TABLET;ORAL021035-002Nov 30, 1999RXNo8,802,142*PED► subscribeY► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: KEPPRA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
KEPPRA
levetiracetam
INJECTABLE;IV (INFUSION)021872-001Jul 31, 20064,943,639*PED► subscribe
Ucb Inc
KEPPRA
levetiracetam
TABLET;ORAL021035-001Nov 30, 19994,943,639*PED► subscribe
Ucb Inc
KEPPRA
levetiracetam
TABLET;ORAL021035-004Jan 6, 20064,943,639*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: KEPPRA

Drugname Dosage Strength RLD Submissiondate
levetiracetamExtended-release Tablet500 mg and 750 mgKeppra XL1/7/2011
levetiracetamTablets1000 mgKeppra1/24/2007
levetiracetamExtended-release Tablets1000 mgKeppra XR1/7/2011
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc